FDA Approves Wegovy to Reduce Heart Disease and Stroke Risk in People With Obesity The FDA has now approved Wegovy to reduce cardiovascular risk in people with obesity, in a label expansion based on results from Novo Nordisks SELECT trial
Ferretti F, Cannatelli R, Monico MC, Maconi G, Ardizzone S
Gut health support through probiotics also plays a role in fluid balance and bloating reduction, both of which can unmask weight loss that was being hidden by water retention and digestive stasis
While not a direct cure, maintaining adequate B12 levels can improve overall skin resilience
We love them mid-morning, after a workout, or as a light dinner
Sinus infections and the common cold are good examples